Skip to main content
. 2023 Feb 9;27(6):1130–1140. doi: 10.1007/s11605-023-05610-2

Table 1.

Baseline characteristics of the study cohort

Characteristic Value
Age, year 51 (44–58)
Gender
  Male/female 42 (59.2)/29 (40.8)
Etiology
  Hepatitis B virus/Schistosomiasis japonica/hepatitis C virus/others 43 (60.6) / 11 (15.5) / 3(4.2%)/14 (19.7%)
History of variceal hemorrhage
  With/without 29 (40.8) / 42 (59.2)
Concomitant PVST
  With/without 7 (9.9) / 64 (90.1)
Hemoglobin, g/L 103 (83-128)
Leukocyte count, × 109/L 2.62 (1.85-3.44)
Platelet count, × 109/L 45.0 (35.0-60.5)
AST, U/L 33.00 (24.63-46.23)
ALT, U/L 28.0 (17.9-42.1)
Serum albumin, g/L 35.6 (32.3-40.6)
Serum total bilirubin, μmol/L 19.7 (14.9-28.6)
Serum creatinine, μmol/L 61.8 (52.6-75.9)
PT, s 14.5 (13.1-15.5)
INR 1.2 (1.1-1.3)
ALBI grade
  1/2/3 20 (28.2) / 43 (60.6) / 8 (11.2)
Child–Pugh grade
  A/B 54 (76.1) / 17 (23.9)
Esophagogastric devascularization
  With/without 44 (62.0) / 27 (38.0)
Operation method
  Laparoscopy/laparotomy 24 (33.8) / 47 (66.2)
Liver volume, cm3 914 (825.0-1048.5)
Spleen volume, cm3 776 (547.0-1005.0)
Liver/spleen volume ratio 1.23 (0.91-1.76)

Values are presented as median (IQR) for quantitative variables and n (%) for categorical variables

Abbreviations: PVST, portal venous system thrombosis; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PT, prothrombin time; INR, international normalized ratio; ALBI, albumin-bilirubin